Kari Schmidt

710 total citations
6 papers, 211 citations indexed

About

Kari Schmidt is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmaceutical Science. According to data from OpenAlex, Kari Schmidt has authored 6 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Oncology and 2 papers in Pharmaceutical Science. Recurrent topics in Kari Schmidt's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Metabolism and Genetic Disorders (1 paper). Kari Schmidt is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Metabolism and Genetic Disorders (1 paper). Kari Schmidt collaborates with scholars based in United States and Germany. Kari Schmidt's co-authors include Frederick Nelson, Lin Zhou, Bo Feng, Matthew D. Troutman, Katrina L. Mealey, John Gay, David Raunig, Rodney S. Bagley, Stephen J. Greene and Patrick R. Gavin and has published in prestigious journals such as Biochemical Pharmacology, Drug Metabolism and Disposition and European Journal of Pharmaceutical Sciences.

In The Last Decade

Kari Schmidt

6 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Schmidt United States 5 150 95 53 26 23 6 211
Thomas Mehrens Germany 7 204 1.4× 73 0.8× 109 2.1× 27 1.0× 14 0.6× 10 379
Rhonda R. Holley-Shanks United States 6 98 0.7× 43 0.5× 67 1.3× 21 0.8× 52 2.3× 6 207
Oktay F. Rifki United States 5 66 0.4× 49 0.5× 156 2.9× 14 0.5× 75 3.3× 6 320
Ana Santoro Brazil 8 62 0.4× 69 0.7× 132 2.5× 14 0.5× 74 3.2× 11 338
Alexander Traxl Austria 11 239 1.6× 119 1.3× 64 1.2× 15 0.6× 29 1.3× 17 326
Hiroyuki Takita Japan 6 72 0.5× 46 0.5× 32 0.6× 9 0.3× 29 1.3× 12 150
Takayuki Seo Japan 10 246 1.6× 357 3.8× 76 1.4× 38 1.5× 98 4.3× 15 532
Kenya Nakai Japan 10 91 0.6× 20 0.2× 43 0.8× 38 1.5× 53 2.3× 15 320
Paul L. Barclay United Kingdom 11 94 0.6× 29 0.3× 110 2.1× 18 0.7× 15 0.7× 18 370
Lucille Mellottée France 3 45 0.3× 20 0.2× 50 0.9× 13 0.5× 77 3.3× 4 193

Countries citing papers authored by Kari Schmidt

Since Specialization
Citations

This map shows the geographic impact of Kari Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Schmidt more than expected).

Fields of papers citing papers by Kari Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Schmidt. The network helps show where Kari Schmidt may publish in the future.

Co-authorship network of co-authors of Kari Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Schmidt. A scholar is included among the top collaborators of Kari Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Schmidt. Kari Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Mealey, Katrina L., et al.. (2010). Oral bioavailability of P‐glycoprotein substrate drugs do not differ betweenABCB1‐1Δ andABCB1 wild type dogs. Journal of Veterinary Pharmacology and Therapeutics. 33(5). 453–460. 23 indexed citations
3.
Schmidt, Christopher J., John F. Harms, F. David Tingley, et al.. (2009). P2‐241: PDE9A‐mediated regulation of cGMP: Developing a biomarker for a novel therapy for Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_11). 7 indexed citations
4.
Mealey, Katrina L., Stephen J. Greene, Rodney S. Bagley, et al.. (2008). P-Glycoprotein Contributes to the Blood-Brain, but Not Blood-Cerebrospinal Fluid, Barrier in a Spontaneous Canine P-Glycoprotein Knockout Model. Drug Metabolism and Disposition. 36(6). 1073–1079. 38 indexed citations
5.
Lanz, Thomas A., Christopher T. Salatto, M. Marconi, et al.. (2007). Peripheral elevation of IGF-1 fails to alter Aβ clearance in multiple in vivo models. Biochemical Pharmacology. 75(5). 1093–1103. 29 indexed citations
6.
Spahn‐Langguth, H., et al.. (1994). P168 pharmacokinetics of talinolol enantiomers in plasma, urine and bile after oral and intravenous administration of the racemate. European Journal of Pharmaceutical Sciences. 2(1-2). 160–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026